PERBRONS 10 MG 120 ML SYRUP – What is it, Uses & 2026 Price in Turkey

Clinical Data Review: Comprehensive profile for PERBRONS 10 MG 120 ML SYRUP, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: PERBRONS 10 MG 120 ML SYRUP

Manufacturer: CASEL PHARMACIST CAHİT SELİMOĞLU PHARMACEUTICAL INDUSTRY AND TRADE LIMITED COMPANY

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

OKSOLAMIN 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

PERBRONS 10 MG 120 ML SYRUP is formulated with OKSOLAMIN, a clinically established agent in medical practice.

  • Mechanism of Action: OKSOLAMIN acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to OKSOLAMIN therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name PERBRONS 10 MG 120 ML SYRUP
Barcode (GTIN) 8699649570047
Generic Name OKSOLAMIN
License Holder CASEL PHARMACIST CAHİT SELİMOĞLU PHARMACEUTICAL INDUSTRY AND TRADE LIMITED COMPANY
Pharmacy Retail Price 132.81 TL
⚠️ Clinical Safety Warning

Do not administer PERBRONS 10 MG 120 ML SYRUP if the patient has a known hypersensitivity or allergy to OKSOLAMIN. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.


Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via CASEL PHARMACIST CAHİT SELİMOĞLU PHARMACEUTICAL INDUSTRY AND TRADE LIMITED COMPANY.

Leave a Comment